Consolidated Statement of Changes in Equity - USD ($)	Total		Cumulative Effect, Period of Adoption, Adjustment	Total Stockholders' Equity	Total Stockholders' Equity Cumulative Effect, Period of Adoption, Adjustment	Preferred Stock	Common Stock	Additional Paid-in Capital	Cumulative Distributions to Stockholders	Accumulated Earnings	Accumulated Earnings Cumulative Effect, Period of Adoption, Adjustment	Noncontrolling interests
Beginning balance (in shares) at Dec. 31, 2022						2,400,000
Balance at Dec. 31, 2022	$ 243,001,497		$ (3,591,440)	$ 242,901,997	$ (3,591,440)	$ 57,254,935	$ 522,252	$ 314,598,384	$ (160,724,426)	$ 31,250,852	$ (3,591,440)	$ 99,500
Beginning balance (in shares) at Dec. 31, 2022							52,231,152
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Cost of issuing common stock	(14,040)			(14,040)				(14,040)
Restricted stock compensation expense	3,358			3,358				3,358
Net income	5,766,691			5,766,691						5,766,691
Common stock dividends	(3,133,869)			(3,133,869)					(3,133,869)
Preferred stock dividends	(1,184,958)			(1,184,958)					(1,184,958)
Ending balance (in shares) at Mar. 31, 2023						2,400,000
Balance at Mar. 31, 2023	$ 240,847,239			240,747,739		$ 57,254,935	$ 522,252	314,587,702	(165,043,253)	33,426,103		99,500
Ending balance (in shares) at Mar. 31, 2023							52,231,152
Beginning balance (in shares) at Dec. 31, 2023	2,400,000					2,400,000
Balance at Dec. 31, 2023	$ 240,792,380	[1]		240,692,880		$ 57,254,935	$ 522,487	314,587,299	(179,045,749)	47,373,908		99,500
Beginning balance (in shares) at Dec. 31, 2023	52,248,631						52,248,631
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock (in shares)							8,684
Issuance of common stock	$ 19,947			19,947			$ 87	19,860
Cost of issuing common stock	(14,196)			(14,196)				(14,196)
Restricted stock compensation expense	0
Net income	6,980,182			6,980,182						6,980,182
Common stock dividends	(3,658,012)			(3,658,012)					(3,658,012)
Preferred stock dividends	$ (1,184,999)			(1,184,999)					(1,184,999)
Ending balance (in shares) at Mar. 31, 2024	2,400,000					2,400,000
Balance at Mar. 31, 2024	$ 242,935,302	[1]		$ 242,835,802		$ 57,254,935	$ 522,574	$ 314,592,963	$ (183,888,760)	$ 54,354,090		$ 99,500
Ending balance (in shares) at Mar. 31, 2024	52,257,315						52,257,315

[1] Our consolidated balance sheets include assets and liabilities of consolidated variable interest entities ("VIEs") as the Company was the primary beneficiary of these VIEs. As of March 31, 2024 and December 31, 2023, assets of consolidated VIEs totaled $1,311,421,901 and $1,384,136,334, respectively and the liabilities of consolidated VIEs totaled $1,079,644,656 and $1,150,207,290 respectively. See Note 4 for further discussion.